Oncotarget

Full text - http://bit.ly/28Ncmoy

Oncotarget | Interview with Dr. René Bernards & Diede Brunen - Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands - talking about their cover paper published in Volume 7 Issue 25 of Oncotarget called "Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2ocULhq

Interview with Dr. Raz with the Department of Orthopaedics, Leiden University Medical Center, in the Leiden Netherlands talking about their featured cover paper in Oncotarget Volume 7 Number 8 "Molecular signatures of age-associated chronic degeneration of shoulder muscles"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/1TYK5Rg

Oncotarget | Interview with Dr. Markus D. Siegelin & Dr. Georg Karpel-Massler - Department of Pathology & Cell Biology, Columbia University Medical Center, New York, New York, U.S.A. talking about their cover paper published in Volume 7 Issue 23 of Oncotarget called "Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2pgqWjW

Oncotarget | Interview with Dr. Kelber from the Department of Biology, California State University Northridge, Northridge, CA talking about their featured cover paper in Oncotarget Volume 8 Issue 4 "A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2duVAwX

Oncotarget | Interview with Dr. Joyce Schroeder - Professor Molecular & Cellular Biology and BIO5 Institute Chief Scientific Officer at the Arizona Cancer Therapeutics Carcinogenesis Department of Molecular and Cellular Biology University of Arizona, Tucson, Arizona speaking about their Cover Paper in Oncotarget Volume 7 Issue 38 "Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2yVSSPa

Oncotarget | Interview with Dr. Jaclyn Hechtman from the Department of Pathology Memorial Sloan Kettering Cancer Center, New York, NY, USAtalking about their Cover paper - Volume 7 Issue 32 - Oncotarget -"Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2yTX4uJ

Oncotarget | Interview with Dr. Gregory J. Riggins from the Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD, USA talking about their featured cover paper published in Volume 8 Issue 46 titled "Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients".

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2xAJ4bQ

Oncotarget | Interview with Dr. Fon Tacer from the Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA (currently with St. Judes Children's Hospital, Department of Cell and Molecular Biology in Tennessee, USA) talking about their research in Volume 7 Issue 3 titled "γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2hTOg0O

Oncotarget | Interview with Dr. Dmitrovsky from the University of Texas MD Anderson Cancer Center, Houston, TX talking about their featured cover paper in Oncotarget Volume 8 Issue 1 "The ISG15-specific protease USP18 regulates stability of PTEN"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com

Full text - http://bit.ly/2yWQ6Jx

Oncotarget | Interview with Dr. Bruno Larrivee from Departments of Biomedical Sciences, Molecular Biology and Ophthalmology - Maisonneuve-Rosemont Hospital Research Center, University of Montreal, Montreal, Quebec, Canada & Department of Biological Sciences Université du Québec à Montréal, Montréal, Quebec, Canada talking about their featured cover paper in Oncotarget Volume 7 Issue 35 "BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration"

Facebook - http://bit.ly/2xznxjV

Twitter - http://bit.ly/2xzWvsu

LinkedIn - http://bit.ly/2xzJ6kc

Pintrest - http://bit.ly/2xzX8SS

Reddit - http://bit.ly/2hoxI0N

www.Oncotarget.com